跳至主要内容
临床试验/IRCT20240318061327N1
IRCT20240318061327N1招募中3 期

A comparison of intravenous magnesium sulfate plus ketamine versus intravenous ketamine alone for acute pain control in long bone fractures

Ahvaz University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • All patients with long bone fractures aged 18 to 65 years and weighing between 60 to 80 kg and with a vas scoring pain level of more than 4 out of 10 have referred to the Golestan hospital emergency room, and there was no pain relief intervention before that, including the prescription of any medication. have not had

排除标准

  • Unstable hemodynamics, alcohol consumption, neuromuscular diseases, pregnant and lactating women, high blood pressure (systolic more than 145 mmHg and diastolic more than 100 mmHg), history of benzodiazepine and ketamine use, medical diseases (such as heart failure, liver, kidney, stomach ulcer, cardiac arrhythmia).

研究者

相似试验